Thought Leader Select Part of a New Wave of Pharma Partners

An interesting article popped up this week in PharmaLive’s Product Marketing Weekly.  Highlighting a new wave of external partners defining Pharma 3.0, the article focused on the effects of downsizing in the industry, and how pharmaceutical companies, now more than ever, are turning to external partners for non-core business functions.

At Thought Leader Select, we have implemented key opinion leader identification and profiling for dozens of the world’s leading pharmaceutical and biotechnology companies.  Our research fuels superior KOL deployment across the array of applications in which companies use their thought leaders.  We have proven ourselves to be a key partner in the development and marketing of new drug therapies since our founding.

Check out the PharmaLive article here:

More Posts

New White Paper on Patient Engagement

Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the

New White Paper on Building Speakers Bureaus

The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs


Send Us A Message